HJKC3-007: Outcomes of patients with chronic myeloid leukemia in chronic phase treated with asciminib and other tyrosine kinase inhibitors in routine clinical practice Meeting Abstract
| Authors: | Mauro, M.; Atallah, E. L.; Thompson, J. E.; Gao, Y.; Visotcky, A.; Giever, E.; Baim, A.; Akinola, I.; Larson, R. A.; Jamy, O.; Cortes, J.; Druker, B. J.; Shah, N. P.; Pinilla-Ibarz, J.; Yang, J.; Ritchie, E. K.; Rein, L. A. M.; Tantravahi, S. K.; Badar, T.; Smith, B. D.; Deininger, M. W.; Flynn, K. E. |
| Abstract Title: | HJKC3-007: Outcomes of patients with chronic myeloid leukemia in chronic phase treated with asciminib and other tyrosine kinase inhibitors in routine clinical practice |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 7434 |
| Language: | English |
| ACCESSION: | WOS:001159900808188 |
| DOI: | 10.1182/blood-2023-188683 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
